Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
69 Leser
Artikel bewerten:
(0)

World Market for Microarrays Report 2016 Featuring Illumina, Affymetrix, Agilent, and bioMerieux

DUBLIN, Feb. 22, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7fhv5g/the_world_market) has announced the addition of the "The World Market for Microarrays" report to their offering.

Microarrays are an important tool used in functional genomics for understanding biological data. Advancements in technology have led to the development of more sophisticated techniques, instruments, data analysis, and management tools for studying genetics.

The current market is rapidly evolving with companies making substantial investments on research and development to develop new technologies and identify new therapies and diagnostic tests. Certified service providers offer microarray base services including genome-studies such as genome expression, SNP (single nucleotide polymorphism), CNV (copy-number variation), epigenetic mapping and diagnostic services.

Market players in microarray technology work closely with a broad network of service providers utilizing their technology platforms (or products, instruments or software) for successful execution of services.

World Market for Microarrays analyzes the current and future markets for microarrays, including:

  • Overview of Microarrays
  • Technology
  • DNA Microarrays
  • DNA Microarrays - High Growth Applications
  • Protein Microarrays
  • Lab-on-a-Chip Technology

Market analysis in this report includes the following:

  • Microarray Products and Services, Worldwide, 2015
  • DNA Microarray Market Growth, 2015-2020
  • Lab-on-a-Chip Market Growth, 2015-2020
  • Protein Microarray Market Growth, 2015-2020
  • Other Microarray Market Growth, 2015-2020
  • Microarray Sales by Geographic Region, 2015 (North America, Europe, Asia, ROW)
  • DNA Microarray Market, Research vs. Clinical, 2015
  • Lab-on-a-Chip Market, Research vs. Clinical, 2015

The report profiles companies involved in the microarrays market, including Illumina, Affymetrix, Agilent, and bioMerieux.

Key Topics Covered:

ONE: EXECUTIVE SUMMARY

1.1 Overview

1.2 Scope and Methodology

1.3 Market Overview

1.4 Future Prospects for Microarrays

TWO: MARKET DYNAMICS

2.1 Mergers and Acquisitions

2.2 Agreements with Other Companies

2.3 Market Drivers and Constraints

THREE: OVERVIEW OF MICROARRAYS

3.1 Types of Microarrays

FOUR: TECHNOLOGY

4.1 Production of Microarrays

4.2 Substrates and Surface Chemistries

4.3 Next Generation Microarrays

4.4 Data Management and Informatics in Gene Expression

FIVE: DNA MICROARRAYS

5.1 Applications

DNA Microarrays in Gene Expression

5.2 DNA Microarrays in SNP Analysis

5.3 DNA Microarrays in Cancer

5.4 Other Scanners/Readers

SIX: DNA MICROARRAYS - HIGH GROWTH APPLICATIONS

6.1 Epigenetic Mapping Arrays

6.2 Tiling Arrays

6.3 Growth of Next Generation Sequencing

SEVEN: PROTEIN MICROARRAYS

7.1 Protein Microfilling Microarrays - Antibody Arrays (Also Called Forward Phase Protein Arrays)

7.2 Protein Profiling Microarrays-Reverse Phase Microarrays or Protein Lysate Microarrays

7.3 Functional Protein Microarrays

7.4 Multiplex Sandwich Immunoassays - Planar and Bead-Based

7. 5 Specialized and High Growth Applications

7.6 New Protein Arrays or Emerging Protein Arrays - Protein Nanoarrays

7.7 Nucleic Acid Programmable Protein Arrays

7.8 Peptoid Arrays

7.9 Applications

7.10 Protein Biomarkers

7.11 Cytokine Applications

EIGHT: INTRODUCTION TO LAB-ON-A-CHIP TECHNOLOGY

8.1 Lab-on-a-Chip Technology

8.2 Applications for Lab-on-a-Chip

8.3 Barriers to Widespread Adaptation

8.4 Advantages of Lab-on-a-Chip

8.5 Patents

8.6 Trend for the Future: Lab-on-a-Chip to Enable Mobile Health (mHealth)

NINE: MARKET ANALYSIS

9.1 Overview

9.2 Market Summary

9.3 DNA Microarrays

9.4 Lab-on-a-Chip Market

9.5 Protein Microarray Market

9.6 Other Microarray Market

9.7 Sales by Region

9.8 Clinical and Research Markets

TEN: COMPANY PROFILES

  • Affymetrix, Inc.
  • Agilent Technologies Inc.
  • Applied Microarrays, Inc.
  • Ariosa Diagnostics, Inc. (A Roche Company)
  • ArrayIt Corporation / Avant Diagnostics, Inc
  • Aurora Life Sciences, LLC
  • Avant Diagnostics, Inc. (formerly Arrayit Diagnostics, Inc.)
  • Axela, Inc
  • AXO Science
  • AYOXXA Biosystems GmbH
  • Bio-Rad Laboratories, Inc.
  • Caprion, Inc.
  • CDI Laboratories
  • Cepheid
  • Fluidigm Corporation
  • GE Healthcare Life Sciences
  • Illumina
  • Enterprise Informatics
  • InDevR, Inc.
  • Luminex Corporation
  • Nanosphere, Inc.
  • Oxford Gene Technology
  • PerkinElmer, Inc. (PE)
  • Phalanx Biotech Group
  • RayBiotech
  • Sequenom, Inc
  • Sigma-Aldrich Corporation
  • SomaLogic, Inc.
  • SQI Diagnostics Inc.
  • Theranostics Health Inc.
  • Thermo Fisher Scientific Inc.
  • U.S Biomax, Inc.

For more information visit http://www.researchandmarkets.com/research/7fhv5g/the_world_market

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.